Income Statement Formosa Laboratories, Inc.

Stocks

4746

TW0004746003

Pharmaceuticals

End-of-day quote Taiwan S.E. Other stock markets 2026-07-31			5-day change	1st Jan Change
50.70 ^TWD	+2.74%		-0.98%	-14.50%

05-14	Formosa Laboratories, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
03-16	Formosa Laboratories, Inc. Receives US FDA Approval For Eribulin Injection Under ANDA Pathway	CI

23b7110a5e29dda77ffea1a1a6.WQnOv9VmmJEJ3q0ftHg14J-ZspSh8MCXT8GHBZr3_Oc.PW2WjrQwrMBivJRVzAthjO3ph-Lku7PeC4TKNPOmiYU_Y6DXkyCtzkybmQ

Published financial data: FORMOSA LABORATORIES, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	3.14B	3.77B	4.36B	4.73B	4.85B
Total Revenues	3.14B	3.77B	4.36B	4.73B	4.85B
Cost of Goods Sold, Total	2.17B	2.38B	2.44B	2.68B	2.82B
Gross Profit	971M	1.39B	1.92B	2.05B	2.03B
Selling General & Admin Expenses, Total	453M	421M	433M	502M	510M
Provision for Bad Debts	-13.87M	28.35M	-26.46M	24.14M	-9.06M
R&D Expenses	700M	777M	842M	796M	728M
Other Operating Expenses, Total	1.14B	1.23B	1.25B	1.32B	1.23B
Operating Income	-168M	163M	675M	726M	803M
Interest Expense, Total	-28.05M	-19.32M	-34.74M	-39.61M	-33.12M
Interest And Investment Income	357K	2.14M	23.71M	32.24M	32.26M
Net Interest Expenses	-27.69M	-17.18M	-11.03M	-7.38M	-867K
Income (Loss) On Equity Invest.	9.17M	7.59M	5.56M	-2.16M	8.71M
Currency Exchange Gains (Loss)	-6.86M	10.38M	-65.78M	25.98M	-163M
Other Non Operating Income (Expenses)	1.32B	169M	-427M	7.38M	35.55M
EBT, Excl. Unusual Items	1.12B	333M	177M	750M	683M
Gain (Loss) On Sale Of Investments	-	-	-	-523M	-182M
Gain (Loss) On Sale Of Assets	114K	51K	88K	-21.61M	88K
Other Unusual Items	-36.9M	24K	-34.51M	-6.9M	5K
EBT, Incl. Unusual Items	1.09B	333M	142M	198M	502M
Income Tax Expense	44.01M	116M	195M	134M	106M
Earnings From Continuing Operations	1.04B	217M	-52.26M	64.08M	396M
Net Income to Company	1.04B	217M	-52.26M	64.08M	396M
Minority Interest	206M	193M	179M	93.19M	45.08M
Net Income - (IS)	1.25B	409M	126M	157M	441M
Net Income to Common Incl Extra Items	1.25B	409M	126M	157M	441M
Net Income to Common Excl. Extra Items	1.25B	409M	126M	157M	441M
Per Share Items
Net EPS - Basic	10.92	3.4	1.05	1.31	3.67
Basic EPS - Continuing Operations	10.92	3.4	1.05	1.31	3.67
Basic Weighted Average Shares Outstanding	114M	120M	120M	120M	120M
Net EPS - Diluted	10.32	3.39	1.05	1.3	3.64
Diluted EPS - Continuing Operations	10.32	3.39	1.05	1.3	3.64
Diluted Weighted Average Shares Outstanding	121M	121M	120M	121M	121M
Normalized Basic EPS	7.94	3.33	2.4	4.67	3.93
Normalized Diluted EPS	7.48	3.32	2.4	4.64	3.89
Dividend Per Share	2	1	2	3	3
Payout Ratio	-	58.75	95.26	152.93	81.79
Supplemental Items
EBITDA	297M	624M	1.13B	1.23B	1.34B
EBITA	-149M	181M	692M	743M	825M
EBIT	-168M	163M	675M	726M	803M
EBITDAR	-	-	-	-	-
Effective Tax Rate - (Ratio)	4.05	34.93	136.7	67.66	21.07
Total Current Taxes	25.18M	140M	181M	178M	194M
Total Deferred Taxes	18.83M	-23.93M	13.9M	-11.02M	-30.77M
Normalized Net Income	908M	401M	289M	562M	472M
Interest Capitalized	22.95M	33.5M	43M	39.5M	42.53M
Interest on Long-Term Debt	5.6M	-	-	-	-
Non-Cash Pension Expense	66K	81K	281K	274K	369K
Supplemental Operating Expense Items
Selling and Marketing Expenses	171M	187M	188M	213M	229M
General and Administrative Expenses	282M	234M	245M	289M	281M
Research And Development Expense From Footnotes	700M	777M	842M	796M	728M
Net Rental Expense, Total	-	-	-	-	-
Imputed Operating Lease Interest Expense	-	-	-	-	-
Imputed Operating Lease Depreciation	-	-	-	-	-
Stock-Based Comp., Other (Total)	-	2.59M	2.42M	36.2M	354K
Total Stock-Based Compensation	-	2.59M	2.42M	36.2M	354K

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	730M	1.28B	1.53B	1.36B	1.14B
Short Term Investments	-	154M	831M	1.22B	1.2B
Trading Asset Securities, Total	364M	198M	153M	119M	150M
Total Cash And Short Term Investments	1.09B	1.63B	2.51B	2.7B	2.49B
Accounts Receivable, Total	774M	812M	960M	1.2B	1.09B
Other Receivables	29.42M	14.65M	64.44M	62.44M	77.59M
Total Receivables	803M	827M	1.02B	1.26B	1.17B
Inventory	1.64B	1.6B	1.6B	1.71B	1.72B
Prepaid Expenses	79.81M	89.49M	109M	192M	168M
Other Current Assets, Total	3.81M	2.24M	2.02M	2.52M	1.64M
Total Current Assets	3.62B	4.15B	5.24B	5.87B	5.55B
Gross Property Plant And Equipment	8.53B	8.96B	9.53B	10.12B	10.58B
Accumulated Depreciation	-2.63B	-3.04B	-3.46B	-3.91B	-4.36B
Net Property Plant And Equipment	5.9B	5.92B	6.07B	6.2B	6.23B
Long-term Investments	2.08B	2.25B	1.95B	1.48B	1.29B
Goodwill	30.54M	30.54M	30.54M	60.4M	60.4M
Other Intangibles, Total	217M	192M	174M	155M	293M
Deferred Tax Assets Long-Term	72.3M	97.19M	85.15M	93.04M	117M
Other Long-Term Assets, Total	93.43M	106M	85.42M	33.46M	303M
Total Assets	12.02B	12.75B	13.64B	13.9B	13.83B
Liabilities
Accounts Payable, Total	204M	187M	203M	219M	282M
Accrued Expenses, Total	394M	451M	468M	606M	620M
Short-term Borrowings	1.18B	1.5B	1.53B	733M	1.11B
Current Portion of Long-Term Debt	285M	619M	449M	388M	440M
Current Portion of Leases	27.74M	22.09M	23.36M	26.07M	23.76M
Current Income Taxes Payable	22.89M	141M	98.7M	69.45M	30.94M
Unearned Revenue Current, Total	110M	55.78M	175M	62.19M	126M
Other Current Liabilities	165M	165M	291M	252M	264M
Total Current Liabilities	2.39B	3.14B	3.24B	2.36B	2.9B
Long-Term Debt	1.91B	1.64B	2.04B	2.67B	1.95B
Long-Term Leases	23.5M	21.44M	19.39M	82.41M	83.07M
Unearned Revenue Non Current	-	16.99M	18.23M	28.94M	26.08M
Pension & Other Post Retirement Benefits	17.38M	16.85M	23.37M	25.18M	25.82M
Deferred Tax Liability Non Current	23.94M	24.63M	24.3M	20.97M	13.46M
Other Non Current Liabilities	57.2M	95.13M	61.41M	65.57M	165M
Total Liabilities	4.41B	4.95B	5.43B	5.25B	5.16B
Common Stock, Total	1.2B	1.2B	1.2B	1.2B	1.2B
Additional Paid In Capital	3.5B	3.51B	3.55B	3.77B	3.57B
Retained Earnings	2.64B	2.81B	2.81B	2.73B	3.01B
Comprehensive Income and Other	49.26M	-5.7M	6.17M	-18.2M	-26.34M
Total Common Equity	7.4B	7.52B	7.57B	7.68B	7.76B
Minority Interest	207M	276M	639M	963M	913M
Total Equity	7.6B	7.8B	8.21B	8.65B	8.67B
Total Liabilities And Equity	12.02B	12.75B	13.64B	13.9B	13.83B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	120M	120M	120M	120M	120M
ECS Total Common Shares Outstanding	120M	120M	120M	120M	120M
Book Value / Share	61.5	62.54	62.96	63.9	64.51
Tangible Book Value	7.15B	7.3B	7.37B	7.47B	7.4B
Tangible Book Value Per Share	59.44	60.68	61.26	62.11	61.57
Total Debt	3.42B	3.8B	4.06B	3.9B	3.61B
Net Debt	2.33B	2.17B	1.55B	1.2B	1.12B
Debt Equivalent of Unfunded Proj. Benefit Obligation	17.38M	16.85M	23.37M	25.18M	25.82M
Debt Equivalent Oper. Leases	-	-	-	-	-
Minority Interest, Total (Incl. Fin. Div)	207M	276M	639M	963M	913M
Equity Method Investments, Total	8.11M	15.42M	19.81M	17.04M	24.53M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	563M	623M	570M	665M	565M
Inventories - Work In Process, Total	519M	501M	436M	457M	593M
Inventories - Finished Goods, Total	865M	860M	905M	969M	1.06B
Land - (BS)	656M	656M	656M	656M	656M
Buildings, Total	1.58B	1.6B	2.38B	2.45B	2.54B
Machinery, Total	3.94B	4.12B	4.48B	4.89B	5.16B
Accumulated Allowance for Doubtful Accounts (Supple)	5.43M	33.78M	7.32M	31.46M	14.57M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	1.25B	409M	126M	157M	441M
Depreciation & Amortization - CF	446M	442M	462M	482M	519M
Amortization of Goodwill and Intangible Assets - (CF)	18.95M	17.88M	17.48M	17.37M	21.98M
Depreciation & Amortization, Total	465M	460M	480M	499M	541M
Amortization of Deferred Charges, Total - (CF)	10.39M	10.58M	8.37M	7.58M	8.23M
(Gain) Loss From Sale Of Asset	-114K	-51K	-88K	21.61M	-88K
(Gain) Loss on Sale of Investments - (CF)	-1.3B	-179M	429M	523M	182M
(Income) Loss On Equity Investments - (CF)	-9.17M	-7.59M	-5.56M	2.16M	-8.71M
Stock-Based Compensation (CF)	-	2.59M	2.42M	36.2M	354K
Provision and Write-off of Bad Debts	-13.87M	28.35M	-26.46M	24.14M	-9.06M
Other Operating Activities, Total	-144M	-83.46M	-146M	-108M	-97.83M
Change in Trading Asset Securities	1.13M	263K	988K	-	-
Change In Accounts Receivable	2.19M	-69.64M	-121M	-260M	114M
Change In Inventories	-188M	37.52M	4.2M	-114M	-4.15M
Change In Accounts Payable	-5.72M	-15.94M	15.64M	15.92M	-
Change in Unearned Revenues	67.63M	-36.92M	93.08M	-134M	60.86M
Change in Other Net Operating Assets	173M	86.48M	-33.74M	55.04M	88.3M
Cash from Operations	311M	643M	827M	726M	1.32B
Capital Expenditure	-509M	-438M	-539M	-586M	-797M
Sale of Property, Plant, and Equipment	310K	51K	88K	47.44M	910K
Cash Acquisitions	-71.03M	-29.87M	-	-107M	-
Sale (Purchase) of Intangible assets	-5.04M	-1.55M	-1.98M	-1.92M	-46.05M
Investment in Marketable and Equity Securities, Total	-33.05M	-30.97M	-667M	-379M	-1.33M
Other Investing Activities, Total	28.1M	-39.95M	-50.36M	705K	-1.75M
Cash from Investing	-589M	-541M	-1.26B	-1.03B	-845M
Short Term Debt Issued, Total	-	432M	50.05M	-	430M
Long-Term Debt Issued, Total	3.45B	3.4B	4.04B	6.54B	4.88B
Total Debt Issued	3.45B	3.83B	4.09B	6.54B	5.31B
Short Term Debt Repaid, Total	-90.64M	-110M	-15.67M	-804M	-49.98M
Long-Term Debt Repaid, Total	-3.45B	-3.36B	-3.84B	-6B	-5.58B
Total Debt Repaid	-3.54B	-3.47B	-3.85B	-6.8B	-5.63B
Issuance of Common Stock	-	-	-	-	-
Common Dividends Paid	-	-241M	-120M	-241M	-361M
Common & Preferred Stock Dividends Paid	-	-241M	-120M	-241M	-361M
Other Financing Activities, Total	532M	330M	584M	634M	-
Cash from Financing	439M	448M	700M	132M	-678M
Foreign Exchange Rate Adjustments	-12.16M	-383K	-22.77M	5.77M	-15.69M
Net Change in Cash	149M	550M	247M	-161M	-224M
Supplemental Items
Cash Interest Paid	19.78M	17.73M	30.8M	40.49M	33.16M
Cash Income Tax Paid (Refund)	35.92M	21.65M	204M	153M	174M
Levered Free Cash Flow	-171M	234M	372M	-73.97M	412M
Unlevered Free Cash Flow	-154M	246M	394M	-49.21M	433M
Change In Net Working Capital	9.7M	-111M	-21.68M	458M	-224M
Net Debt Issued / Repaid	-92.95M	358M	237M	-261M	-317M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-0.94	0.83	3.2	3.3	3.62
Return on Total Capital	-1.03	0.9	3.53	3.66	4.04
Return On Equity %	16.19	2.82	-0.65	0.76	4.57
Return on Common Equity	19.83	5.49	1.67	2.06	5.71
Margin Analysis
Gross Profit Margin %	30.91	36.92	44.11	43.3	41.89
SG&A Margin	14.42	11.19	9.93	10.62	10.51
EBITDA Margin %	9.44	16.57	25.85	25.9	27.7
EBITA Margin %	-4.74	4.82	15.88	15.71	17.01
EBIT Margin %	-5.35	4.34	15.48	15.34	16.56
Income From Continuing Operations Margin %	33.21	5.76	-1.2	1.35	8.16
Net Income Margin %	39.75	10.87	2.9	3.32	9.09
Net Avail. For Common Margin %	39.75	10.87	2.9	3.32	9.09
Normalized Net Income Margin	28.9	10.64	6.63	11.87	9.73
Levered Free Cash Flow Margin	-5.44	6.22	8.53	-1.56	8.49
Unlevered Free Cash Flow Margin	-4.89	6.54	9.03	-1.04	8.92
Asset Turnover
Asset Turnover	0.28	0.3	0.33	0.34	0.35
Fixed Assets Turnover	0.54	0.64	0.73	0.77	0.78
Receivables Turnover (Average Receivables)	4.1	4.75	4.92	4.39	4.24
Inventory Turnover (Average Inventory)	1.41	1.47	1.52	1.62	1.65
Short Term Liquidity
Current Ratio	1.52	1.32	1.62	2.49	1.91
Quick Ratio	0.79	0.78	1.09	1.68	1.26
Operating Cash Flow to Current Liabilities	0.13	0.2	0.26	0.31	0.45
Days Sales Outstanding (Average Receivables)	89.05	76.88	74.18	83.4	86.05
Days Outstanding Inventory (Average Inventory)	259.78	249	239.56	225.76	221.86
Average Days Payable Outstanding	31.89	30.57	29.3	27.62	32.4
Cash Conversion Cycle (Average Days)	316.94	295.32	284.45	281.53	275.51
Long Term Solvency
Total Debt/Equity	44.99	48.74	49.49	45.1	41.63
Total Debt / Total Capital	31.03	32.77	33.11	31.08	29.39
LT Debt/Equity	25.39	21.28	25.06	31.83	23.44
Long-Term Debt / Total Capital	17.51	14.31	16.76	21.94	16.55
Total Liabilities / Total Assets	36.74	38.86	39.79	37.77	37.32
EBIT / Interest Expense	-5.99	8.46	19.43	18.32	24.25
EBITDA / Interest Expense	10.57	32.29	33.25	30.93	40.58
(EBITDA - Capex) / Interest Expense	-7.56	9.6	17.75	16.14	16.51
Total Debt / EBITDA	11.53	6.09	3.52	3.18	2.69
Net Debt / EBITDA	7.85	3.48	1.34	0.98	0.83
Total Debt / (EBITDA - Capex)	-16.12	20.5	6.59	6.1	6.6
Net Debt / (EBITDA - Capex)	-10.97	11.7	2.52	1.87	2.04
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	2.18	19.83	15.8	8.5	2.54
Gross Profit, 1 Yr. Growth %	2.78	43.11	38.35	6.52	-0.81
EBITDA, 1 Yr. Growth %	-36.57	110.33	89.45	6.09	9.69
EBITA, 1 Yr. Growth %	-423.76	-221.67	281.78	7.34	11.02
EBIT, 1 Yr. Growth %	-699.78	-197.3	312.86	7.54	10.65
Earnings From Cont. Operations, 1 Yr. Growth %	217.01	-79.22	-124.1	-222.61	518.06
Net Income, 1 Yr. Growth %	212.25	-67.23	-69.16	24.58	180.48
Normalized Net Income, 1 Yr. Growth %	205.52	-55.88	-27.88	0.84	-15.93
Diluted EPS Before Extra, 1 Yr. Growth %	198.32	-67.14	-69.03	23.83	180
Accounts Receivable, 1 Yr. Growth %	1.88	5	18.16	24.58	-8.74
Inventory, 1 Yr. Growth %	12.97	-2.29	-0.26	7.14	0.24
Net Property, Plant and Equip., 1 Yr. Growth %	1.73	0.3	2.52	2.25	0.34
Total Assets, 1 Yr. Growth %	16.83	6.11	6.94	1.9	-0.45
Tangible Book Value, 1 Yr. Growth %	44.78	2.1	0.94	1.39	-0.87
Common Equity, 1 Yr. Growth %	42.08	1.7	0.67	1.49	0.95
Cash From Operations, 1 Yr. Growth %	-34.49	106.68	28.54	-12.13	81.08
Capital Expenditures, 1 Yr. Growth %	-49.5	-13.83	22.83	8.81	36.03
Levered Free Cash Flow, 1 Yr. Growth %	-76.74	-236.91	58.87	-119.88	-656.88
Unlevered Free Cash Flow, 1 Yr. Growth %	-78.6	-260.41	59.89	-112.5	-979.15
Dividend Per Share, 1 Yr. Growth %	-	-50	100	50	0
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	6.71	10.65	17.8	12.09	5.48
Gross Profit, 2 Yr. CAGR %	8.5	21.28	40.71	21.4	2.79
EBITDA, 2 Yr. CAGR %	-13.77	15.51	94.96	43.49	7.88
EBITA, 2 Yr. CAGR %	88.52	98.47	115.53	102.44	9.16
EBIT, 2 Yr. CAGR %	162.21	141.58	100.43	110.71	9.08
Earnings From Cont. Operations, 2 Yr. CAGR %	404.12	-18.84	-77.62	-45.64	175.28
Net Income, 2 Yr. CAGR %	936.31	1.16	-68.21	-38.02	86.93
Normalized Net Income, 2 Yr. CAGR %	464.38	16.1	-43.59	18.4	-7.93
Diluted EPS Before Extra, 2 Yr. CAGR %	837.2	-1	-68.1	-38.07	86.21
Accounts Receivable, 2 Yr. CAGR %	-6.6	3.43	11.39	21.33	6.63
Inventory, 2 Yr. CAGR %	14.64	5.06	-1.28	3.37	3.64
Net Property, Plant and Equip., 2 Yr. CAGR %	3.62	1.01	1.41	2.39	1.29
Total Assets, 2 Yr. CAGR %	12.05	11.34	6.52	4.39	0.72
Tangible Book Value, 2 Yr. CAGR %	32.27	21.58	1.52	1.17	0.25
Common Equity, 2 Yr. CAGR %	30.21	20.2	1.18	1.08	1.22
Cash From Operations, 2 Yr. CAGR %	4.11	16.36	62.99	6.28	26.14
Capital Expenditures, 2 Yr. CAGR %	-40.04	-34.04	2.88	15.61	21.66
Levered Free Cash Flow, 2 Yr. CAGR %	-56.12	-43.56	47.48	-43.8	5.22
Unlevered Free Cash Flow, 2 Yr. CAGR %	-58.01	-41.41	60.15	-55.3	4.81
Dividend Per Share, 2 Yr. CAGR %	-	-	0	73.21	22.47
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	5.35	10.92	12.34	14.61	8.81
Gross Profit, 3 Yr. CAGR %	2.05	18.99	26.72	28.24	13.49
EBITDA, 3 Yr. CAGR %	-7.11	16.07	34.09	60.46	31.2
EBITA, 3 Yr. CAGR %	24.58	62.92	146.84	70.84	65.7
EBIT, 3 Yr. CAGR %	40.57	88.43	188.83	62.87	70
Earnings From Cont. Operations, 3 Yr. CAGR %	103.05	74.13	-45.85	-60.55	22.24
Net Income, 3 Yr. CAGR %	91.88	227.71	-31.92	-49.88	2.52
Normalized Net Income, 3 Yr. CAGR %	84.76	141.32	-0.94	-14.8	5.63
Diluted EPS Before Extra, 3 Yr. CAGR %	79.6	206.73	-32.8	-49.87	2.4
Accounts Receivable, 3 Yr. CAGR %	-3.99	-2.88	8.12	15.62	10.34
Inventory, 3 Yr. CAGR %	8.32	8.7	3.26	1.45	2.32
Net Property, Plant and Equip., 3 Yr. CAGR %	14.71	2.5	1.51	1.69	1.7
Total Assets, 3 Yr. CAGR %	11.26	10.03	9.85	4.96	2.75
Tangible Book Value, 3 Yr. CAGR %	20.79	21.34	14.27	1.48	0.48
Common Equity, 3 Yr. CAGR %	18.83	19.91	13.3	1.29	1.04
Cash From Operations, 3 Yr. CAGR %	56.68	30.85	20.28	32.65	26.93
Capital Expenditures, 3 Yr. CAGR %	-20	-32.34	-18.85	4.82	22.05
Levered Free Cash Flow, 3 Yr. CAGR %	-46.29	-35.89	-20.31	-24.38	20.71
Unlevered Free Cash Flow, 3 Yr. CAGR %	-48.02	-34.36	-18.13	-31.57	20.66
Dividend Per Share, 3 Yr. CAGR %	58.74	-	-	14.47	44.22
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-0.3	8.2	10.16	11.38	9.54
Gross Profit, 5 Yr. CAGR %	-5.03	6.69	16.04	19.94	16.54
EBITDA, 5 Yr. CAGR %	-20.41	-0.91	24.96	25.16	23.51
EBITA, 5 Yr. CAGR %	-25.81	-14.07	55.12	77.7	78.1
EBIT, 5 Yr. CAGR %	-24.02	-15.44	62.01	97.04	95.65
Earnings From Cont. Operations, 5 Yr. CAGR %	16.64	-1.62	-15.96	9.31	3.77
Net Income, 5 Yr. CAGR %	20.91	11.4	-6.52	68.35	1.97
Normalized Net Income, 5 Yr. CAGR %	19.14	16.13	14.95	81.51	9.7
Diluted EPS Before Extra, 5 Yr. CAGR %	14.55	5.89	-10.03	61.74	1.03
Accounts Receivable, 5 Yr. CAGR %	-2.32	-0.48	1.89	6.16	7.52
Inventory, 5 Yr. CAGR %	11.94	11.89	4.37	6.54	3.41
Net Property, Plant and Equip., 5 Yr. CAGR %	12.51	10.62	9.19	2.46	1.42
Total Assets, 5 Yr. CAGR %	12.28	11.98	9.34	7.74	6.11
Tangible Book Value, 5 Yr. CAGR %	11.87	14.7	12.68	12.83	8.44
Common Equity, 5 Yr. CAGR %	12.5	13.35	11.43	11.99	8.31
Cash From Operations, 5 Yr. CAGR %	-22.46	10.22	59.18	20.4	22.59
Capital Expenditures, 5 Yr. CAGR %	2.38	-1.34	-11.53	-16.17	-4.58
Levered Free Cash Flow, 5 Yr. CAGR %	-22.46	42.29	-19.55	-39.18	-10.94
Unlevered Free Cash Flow, 5 Yr. CAGR %	-24.6	35.54	-18.47	-43.71	-9.62
Dividend Per Share, 5 Yr. CAGR %	-7.03	-12.94	31.95	-	-